Evidence map›Paper›PMID 30597917›Full record

ArticleGenes2018

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer.

Patricio Gonzalez-Hormazabal, Maher Musleh, Marco Bustamante, Juan Stambuk, Raul Pisano, Hector Valladares, Enrique Lanzarini, Hector Chiong, Jorge Rojas, Jose Suazo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Frontiers in microbiology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Patricio Gonzalez-HormazabalHuman Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago 8380453, Chile. patriciogonzalez@uchile.cl.ORCID 0000-0001-9786-2210
Maher MuslehDepartment of Surgery, University of Chile Clinical Hospital, Santiago 8380456, Chile. mmuslehk@gmail.com.ORCID 0000-0002-4717-0336
Marco BustamanteDepartment of Surgery, School of Medicine at Eastern Campus, University of Chile, Santiago 7500922, Chile. mbustama@med.uchile.cl.
Juan StambukDepartment of Surgery, San Juan de Dios Hospital, Santiago 8350488, Chile. juanstambuk@gmail.com.
Raul PisanoDepartment of Surgery, San Juan de Dios Hospital, Santiago 8350488, Chile. raul.pisano@redsalud.gov.cl.
Hector ValladaresDepartment of Surgery, University of Chile Clinical Hospital, Santiago 8380456, Chile. hvalladares@hcuch.cl.
Enrique LanzariniDepartment of Surgery, University of Chile Clinical Hospital, Santiago 8380456, Chile. elanzarini@hotmail.com.
Hector ChiongDepartment of Surgery, Barros Luco Hospital, Santiago 8900085, Chile. drhectorchiong@gmail.com.
Jorge RojasDepartment of Surgery, University of Chile Clinical Hospital, Santiago 8380456, Chile. jrojascaro@yahoo.com.
Jose SuazoInstitute for Research in Dental Sciences, School of Dentistry, University of Chile, Santiago 8380492, Chile. jsuazo@odontologia.uchile.cl.
V Gonzalo CastroHuman Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago 8380453, Chile. vgcastro@gmail.com.
Lilian JaraHuman Genetics Program, Institute of Biomedical Sciences (ICBM), School of Medicine, University of Chile, Santiago 8380453, Chile. ljara@uchile.cl.
Zoltan BergerDepartment of Gastroenterology, University of Chile Clinical Hospital, Santiago 8380456, Chile. berger.zoltan@gmail.com.
Hospital Clínico de la Universidad de Chile · CLUniversity of Chile · CLHospital San Juan de Dios · CLHospital Barros Luco-Trudeau · CL

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico 1151015
6 · The paper itself

Abstract

The RAS/RAF/MEK/ERK pathway regulates certain cellular functions, including cell proliferation, differentiation, survival, and apoptosis. Dysregulation of this pathway leads to the occurrence and progression of cancers mainly by somatic mutations. This study aimed to assess if polymorphisms of the RAS/RAF/MEK/ERK pathway are associated with gastric cancer. A case-control study of 242 gastric cancer patients and 242 controls was performed to assess the association of 27 single nucleotide polymorphisms (SNPs) in the RAS/RAF/MEK/ERK pathway genes with gastric cancer. Analyses performed under the additive model (allele) showed four significantly associated SNPs:

Indexed as

association studygastric cancerMAPK pathwaypolymorphismRAS/RAF/MEK/ERK pathway

Identifiers

PMID30597917
PMCPMC6356706
OpenAlexW2907880433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.